Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseases

Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseases

US Patent 11292826 · Granted Apr 5, 2022

Estimated economic value: $61,800,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Administration of an anti-activin-a compound to a subject2025
Conversational interface for content creation and editing using large language m2025
Methods for treating muscle wasting and bone disease using novel hybrid ActRIIB 2025
Methods for treating muscle wasting and bone disease using novel hybrid ActRIIB 2025
Conversational interface for content creation and editing using large language m2024
Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseases2024
Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseases2024
Administration of an anti-activin-A compound to a subject2023
Anti-activin A antibodies and uses thereof2023
Dual receptor antagonistic antigen-binding proteins and uses thereof2021
Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseases2021
Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseases2021